176 related articles for article (PubMed ID: 27207629)
1. Tubulin is a molecular target of the Wnt-activating chemical probe.
Fukuda Y; Sano O; Kazetani K; Yamamoto K; Iwata H; Matsui J
BMC Biochem; 2016 May; 17(1):9. PubMed ID: 27207629
[TBL] [Abstract][Full Text] [Related]
2. Identification of a class of novel tubulin inhibitors.
Yi X; Zhong B; Smith KM; Geldenhuys WJ; Feng Y; Pink JJ; Dowlati A; Xu Y; Zhou A; Su B
J Med Chem; 2012 Apr; 55(7):3425-35. PubMed ID: 22435708
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of novel indole-pyrimidine hybrids bearing morpholine and thiomorpholine moieties.
Diao PC; Li Q; Hu MJ; Ma YF; You WW; Hong KH; Zhao PL
Eur J Med Chem; 2017 Jul; 134():110-118. PubMed ID: 28410492
[TBL] [Abstract][Full Text] [Related]
4. Morphological profiling by means of the Cell Painting assay enables identification of tubulin-targeting compounds.
Akbarzadeh M; Deipenwisch I; Schoelermann B; Pahl A; Sievers S; Ziegler S; Waldmann H
Cell Chem Biol; 2022 Jun; 29(6):1053-1064.e3. PubMed ID: 34968420
[TBL] [Abstract][Full Text] [Related]
5. Canonical WNT signaling regulates development of bovine embryos to the blastocyst stage.
Denicol AC; Dobbs KB; McLean KM; Carambula SF; Loureiro B; Hansen PJ
Sci Rep; 2013; 3():1266. PubMed ID: 23405280
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis and Molecular Docking Studies of Novel Indole-Pyrimidine Hybrids as Tubulin Polymerization Inhibitors.
Hu MJ; Zhang B; Yang HK; Liu Y; Chen YR; Ma TZ; Lu L; You WW; Zhao PL
Chem Biol Drug Des; 2015 Dec; 86(6):1491-500. PubMed ID: 26177395
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, anti-cancer evaluation of benzenesulfonamide derivatives as potent tubulin-targeting agents.
Yang J; Yang S; Zhou S; Lu D; Ji L; Li Z; Yu S; Meng X
Eur J Med Chem; 2016 Oct; 122():488-496. PubMed ID: 27423028
[TBL] [Abstract][Full Text] [Related]
8. Discovery and molecular modeling of novel 1-indolyl acetate--5-nitroimidazole targeting tubulin polymerization as antiproliferative agents.
Duan YT; Sang YL; Makawana JA; Teraiya SB; Yao YF; Tang DJ; Tao XX; Zhu HL
Eur J Med Chem; 2014 Oct; 85():341-51. PubMed ID: 25105922
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of phenstatin/isocombretastatin-chalcone conjugates as potent tubulin polymerization inhibitors and mitochondrial apoptotic inducers.
Kamal A; Kumar GB; Vishnuvardhan MV; Shaik AB; Reddy VS; Mahesh R; Sayeeda IB; Kapure JS
Org Biomol Chem; 2015 Apr; 13(13):3963-81. PubMed ID: 25721862
[TBL] [Abstract][Full Text] [Related]
10. Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents.
Kim ND; Park ES; Kim YH; Moon SK; Lee SS; Ahn SK; Yu DY; No KT; Kim KH
Bioorg Med Chem; 2010 Oct; 18(19):7092-100. PubMed ID: 20810285
[TBL] [Abstract][Full Text] [Related]
11. Generation of ligand-based pharmacophore model and virtual screening for identification of novel tubulin inhibitors with potent anticancer activity.
Chiang YK; Kuo CC; Wu YS; Chen CT; Coumar MS; Wu JS; Hsieh HP; Chang CY; Jseng HY; Wu MH; Leou JS; Song JS; Chang JY; Lyu PC; Chao YS; Wu SY
J Med Chem; 2009 Jul; 52(14):4221-33. PubMed ID: 19507860
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel tubulin inhibitors via structure-based hierarchical virtual screening.
Cao R; Liu M; Yin M; Liu Q; Wang Y; Huang N
J Chem Inf Model; 2012 Oct; 52(10):2730-40. PubMed ID: 22992059
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 2,4,5-substituted pyrimidines as a new class of tubulin polymerization inhibitors.
Xie F; Zhao H; Li D; Chen H; Quan H; Shi X; Lou L; Hu Y
J Med Chem; 2011 May; 54(9):3200-5. PubMed ID: 21480626
[TBL] [Abstract][Full Text] [Related]
14. Tubulin inhibitor identification by bioactive conformation alignment pharmacophore-guided virtual screening.
Nagarajan S; Choi MJ; Cho YS; Min SJ; Keum G; Kim SJ; Lee CS; Pae AN
Chem Biol Drug Des; 2015 Nov; 86(5):998-1016. PubMed ID: 25845798
[TBL] [Abstract][Full Text] [Related]
15. Novel Combretastatin-2-aminoimidazole Analogues as Potent Tubulin Assembly Inhibitors: Exploration of Unique Pharmacophoric Impact of Bridging Skeleton and Aryl Moiety.
Chaudhary V; Venghateri JB; Dhaked HP; Bhoyar AS; Guchhait SK; Panda D
J Med Chem; 2016 Apr; 59(7):3439-51. PubMed ID: 26938120
[TBL] [Abstract][Full Text] [Related]
16. Antivascular and antitumor properties of the tubulin-binding chalcone TUB091.
Canela MD; Noppen S; Bueno O; Prota AE; Bargsten K; Sáez-Calvo G; Jimeno ML; Benkheil M; Ribatti D; Velázquez S; Camarasa MJ; Díaz JF; Steinmetz MO; Priego EM; Pérez-Pérez MJ; Liekens S
Oncotarget; 2017 Feb; 8(9):14325-14342. PubMed ID: 27224920
[TBL] [Abstract][Full Text] [Related]
17. Disruption of tubulin polymerization and cell proliferation by 1-naphthylarsonic acid.
Mahinpour R; Riazi G; Shokrgozar MA; Sarbolouki MN; Ahmadian S; Douraghi M; Hadi Alijanvand H; Azadmanesh K; Heidari M; Naghdi Gheshlaghi Z; Moosavi-Movahedi AA
Cell Biol Int; 2012 Apr; 36(4):403-8. PubMed ID: 22214203
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological studies of novel tubulin inhibitors.
Sun Y; Pandit B; Chettiar SN; Etter JP; Lewis A; Johnsamuel J; Li PK
Bioorg Med Chem Lett; 2013 Aug; 23(15):4465-8. PubMed ID: 23790539
[TBL] [Abstract][Full Text] [Related]
19. The small molecule AMBMP disrupts microtubule growth, ciliogenesis, cell polarity, and cell migration.
Werner M; Del Castillo U; Ventrella R; Brotslaw E; Mitchell B
Cytoskeleton (Hoboken); 2018 Oct; 75(10):450-457. PubMed ID: 30315640
[TBL] [Abstract][Full Text] [Related]
20. The Mechanism of the Interactions of Pironetin Analog/Combretastatin A-4 Hybrids with Tubulin.
Torijano-Gutiérrez S; Vilanova C; Díaz-Oltra S; Murga J; Falomir E; Carda M; Redondo-Horcajo M; Díaz JF; Barasoain I; Marco JA
Arch Pharm (Weinheim); 2015 Aug; 348(8):541-7. PubMed ID: 26085125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]